Health
RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia – News-Medical.Net
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and…
RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with…
Continue Reading
-
Noosa News23 hours agoUnlawful wounding charges, Caloundra – Sunshine Coast
-
Business16 hours agoThis artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025
-
General17 hours agoFootballers and movie stars: PM’s Shanghai tourism push
-
General14 hours ago‘Hidden and radical’ power of First Nations women unlocked in big hART’s Punkaliyarra project